Author:
Clayton L M S,Duncan J S,Sisodiya S M,Acheson J F
Publisher
Springer Science and Business Media LLC
Reference6 articles.
1. Willmore LJ, Abelson MB, Ben-Menachem E, Pellock JM, Shields WD . Vigabatrin: 2008 update. Epilepsia 2009; 50 (2): 163–173.
2. Paul SR, Krauss GL, Miller NR, Medura MT, Miller TA, Johnson MA . Visual function is stable in patients who continue long-term vigabatrin therapy: implications for clinical decision making. Epilepsia 2001; 42 (4): 525–530.
3. Best JL, Acheson JF . The natural history of Vigabatrin associated visual field defects in patients electing to continue their medication. Eye 2005; 19 (1): 41–44.
4. Schmitz B, Jokiel B, Schmidt T, Tiel-Wilk K, Ruther K . Visual field defects under treatment with vigabatrin (VGB), carbamazepine (CBZ) and valproate (VPA): a prospective study. Epilepsia 1999; 40 2: 257.
5. Schmitz B, Schmidt T, Jokiel B, Pfeiffer S, Tiel-Wilck K, Ruther K . Visual field constriction in epilepsy patients treated with vigabatrin and other antiepileptic drugs: a prospective study. J Neurol 2002; 249 (4): 469–475.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献